Fei Ma

2.6k total citations
77 papers, 1.8k citations indexed

About

Fei Ma is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Fei Ma has authored 77 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 37 papers in Cancer Research and 17 papers in Oncology. Recurrent topics in Fei Ma's work include Cancer-related molecular mechanisms research (25 papers), MicroRNA in disease regulation (15 papers) and Circular RNAs in diseases (13 papers). Fei Ma is often cited by papers focused on Cancer-related molecular mechanisms research (25 papers), MicroRNA in disease regulation (15 papers) and Circular RNAs in diseases (13 papers). Fei Ma collaborates with scholars based in China, United States and Singapore. Fei Ma's co-authors include Baoliang Guo, Zhiwei Quan, Mingdi Zhang, Qiang Cai, Chunxiao Liu, Cheng Qian, Wenjie Li, Mingzhe Weng, Di Zhou and Lei Zhong and has published in prestigious journals such as The Journal of Experimental Medicine, The EMBO Journal and PLoS ONE.

In The Last Decade

Fei Ma

69 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fei Ma China 27 1.3k 1.0k 249 159 141 77 1.8k
Dongming Su China 22 969 0.7× 555 0.5× 299 1.2× 299 1.9× 162 1.1× 34 1.6k
Alessandro Carrer United States 15 1.4k 1.0× 751 0.7× 387 1.6× 150 0.9× 357 2.5× 22 2.1k
Feng Qi China 22 814 0.6× 472 0.5× 242 1.0× 244 1.5× 164 1.2× 74 1.4k
Beifang Ning China 23 1.4k 1.0× 929 0.9× 509 2.0× 223 1.4× 359 2.5× 36 2.2k
Mi Ran Kang South Korea 17 1.0k 0.8× 448 0.4× 144 0.6× 115 0.7× 261 1.9× 27 1.5k
Chun‐Ping Cui China 24 1.2k 0.9× 426 0.4× 338 1.4× 209 1.3× 210 1.5× 61 1.7k
Song Wei China 20 757 0.6× 430 0.4× 154 0.6× 157 1.0× 228 1.6× 34 1.2k

Countries citing papers authored by Fei Ma

Since Specialization
Citations

This map shows the geographic impact of Fei Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Ma more than expected).

Fields of papers citing papers by Fei Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fei Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Ma. The network helps show where Fei Ma may publish in the future.

Co-authorship network of co-authors of Fei Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Fei Ma. A scholar is included among the top collaborators of Fei Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fei Ma. Fei Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Qin, Shijie, Yali Hou, Xiaoyan Li, et al.. (2025). A complete Sigmodon hispidus genome and dynamic single-cell transcriptomics reveal evolutionarily conserved responses to RSV infection. Science Translational Medicine. 17(816). eadw7535–eadw7535.
3.
Yao, Jiaqi, Chuan Fei Guo, Weifei Zhang, et al.. (2025). Spatiotemporal hydrogel delivery platform with offense and defense functions for intervertebral disc degeneration: Immune and autophagy modulation. Chemical Engineering Journal. 517. 164351–164351.
4.
5.
Zhang, Yiyun, Hanyu Zhang, Yanling Li, et al.. (2025). Lnc‐TPT1‐AS1/CBP/ATIC Axis Mediated Purine Metabolism Activation Promotes Breast Cancer Progression. Cancer Science. 116(6). 1565–1578. 1 indexed citations
6.
Ma, Fei, et al.. (2024). Clinical Radiologic Analysis of 2964 Papillary Breast Lesions. The Breast Journal. 2024(1). 5639017–5639017.
7.
Luo, Yan, et al.. (2024). Transcriptomic profile of premature ovarian insufficiency with RNA-sequencing. Frontiers in Cell and Developmental Biology. 12. 1370772–1370772. 3 indexed citations
8.
Zhang, Jiarui, Yanling Li, Yansong Liu, et al.. (2023). Inhibition of lncRNA PCAT19 promotes breast cancer proliferation. Cancer Medicine. 12(10). 11971–11982. 10 indexed citations
9.
Ma, Fei, et al.. (2023). Association Between the SLC2A2 Gene rs1499821 Polymorphism and Caries Susceptibility. Genetic Testing and Molecular Biomarkers. 27(5). 149–156. 1 indexed citations
10.
Wang, Jinsong, Wenna Wang, Fei Ma, & Haili Qian. (2023). A hidden translatome in tumors—the coding lncRNAs. Science China Life Sciences. 66(12). 2755–2772. 13 indexed citations
11.
Liu, Xiaoqi, et al.. (2023). The Tumor Stemness Indice mRNAsi can Act as Molecular Typing Tool for Lung Adenocarcinoma. Biochemical Genetics. 61(6). 2401–2424. 1 indexed citations
12.
Wang, Shouhua, et al.. (2021). CircPVT1 promotes gallbladder cancer growth by sponging miR-339-3p and regulates MCL-1 expression. Cell Death Discovery. 7(1). 191–191. 9 indexed citations
13.
Yuan, Wei, Wei You, Kun Jia, et al.. (2021). Effects of sulfometuron-methyl on zebrafish at early developmental stages. Ecotoxicology and Environmental Safety. 220. 112385–112385. 17 indexed citations
14.
Xue, Lei, Fengju Chen, Yue Fei, et al.. (2020). Metformin and an insulin/IGF-1 receptor inhibitor are synergistic in blocking growth of triple-negative breast cancer. Breast Cancer Research and Treatment. 185(1). 73–84. 19 indexed citations
15.
Zhou, Di, Yufan Zhang, Chunfu Zhang, et al.. (2020). NIR/photoacoustic imaging of multitype gallbladder cancer using carboxyl/amino functionalized polymer dots. Biomaterials Science. 8(23). 6657–6669. 3 indexed citations
16.
Liu, Xu, Fei Ma, Chunxiao Liu, et al.. (2020). UBE2O promotes the proliferation, EMT and stemness properties of breast cancer cells through the UBE2O/AMPKα2/mTORC1-MYC positive feedback loop. Cell Death and Disease. 11(1). 10–10. 37 indexed citations
17.
Ma, Fei, Lei Zhang, Li Ma, et al.. (2017). MiR-361-5p inhibits glycolytic metabolism, proliferation and invasion of breast cancer by targeting FGFR1 and MMP-1. Journal of Experimental & Clinical Cancer Research. 36(1). 158–158. 66 indexed citations
18.
Zeng, Yong, et al.. (2016). Quantitative assessment of the influence of X-ray repair cross-complementing group 3 rs861539 polymorphism and cutaneous melanoma susceptibility. Archives of Dermatological Research. 308(3). 173–181. 2 indexed citations
19.
Cai, Lu, et al.. (2014). Identification and characterization of complement factor H in Branchiostoma belcheri. Gene. 553(1). 42–48. 3 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dongming Su Breakdown of academic impact, for papers by Alessandro Carrer Breakdown of academic impact, for papers by Feng Qi Breakdown of academic impact, for papers by Beifang Ning Breakdown of academic impact, for papers by Mi Ran Kang Breakdown of academic impact, for papers by Chun‐Ping Cui Breakdown of academic impact, for papers by Song Wei
Rankless by CCL
2026